Jan 20, 2022 (Stock Traders Daily via COMTEX) -- Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in Moderna Inc. Common Stock /zigman2/quotes/205619834/composite MRNA +4.12% with integrated risk controls.
The trading plans were valid at the time this was published, but the support and resistance levels for MRNA change as time passes, and this should be updated in real time. Access those real time updates for this and 1000 other stocks here. Unlimited Real Time Reports
Protection from Market Crashes: Subscribers also get our Tail Risk hedge, Evitar Corte
Use the basic rules of Technical Analysis. Here are some examples: if MRNA is testing support the signal is to buy and target resistance. On the other hand, if resistance is tested, that is a sign to short, and target support. No matter which side the trade is, long or short, the trigger point is both a place to enter and as a risk control.
This data can be used to define Day Trading, Swing Trading, and Long Term Investing plans for MRNA too. All of these are offered here: Access our Real Time Trading Plans
Short MRNA under 282.69, target n/a, stop loss @ 283.51
Buy MRNA over 179.57, target 202.53, Stop Loss @ 179.05
Short MRNA near 179.57, target n/a, Stop Loss @ 180.09.
Buy MRNA over 172.80, target 179.57, Stop Loss @ 172.4
Short MRNA near 172.80, target n/a, Stop Loss @ 173.2.
MRNA Technical Summary | Raw Data for the Trading Plans
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.